Dr. Shiri Shulman from Assuta discusses the importance of continuity in treatment during wartime and innovative therapies ...

Science Corporation's retinal implant allowed some people who lost their central vision to read, play cards, and recognize ...

There are various factors that may potentially increase the risk of developing AMD, such as advancing age (over 50); having a ...

Cataracts, dry eyes, glaucoma, and other eye problems become more common with age. But these can be treated and even cured if ...

Dry AMD is more common, accounting for about 80–90% of cases. It occurs when the macula, the part of the retina responsible for central vision, gradually thins with age, leading to the accumulation of ...

According to a study presented at the American Academy of Ophthalmology’s annual meeting in Chicago, investigational ...

Light therapy could be a useful treatment for the most common form of age-related macular degeneration, a new study says.

Brain-computer interface (BCI) developer Science Corporation today announced preliminary clinical trial results for its Prima ...

Dr Arshad Khanani anticipates presentations offering new strategies to tackle challenges such as macular atrophy and fibrosis, and optimizing dosing intervals in wet AMD.

To date, Vabysmo is approved in more than 100 countries for DME and wet, or neovascular, age-related macular degeneration ...

“The exceptional pace of SOL-1 recruitment reflects the strong continued interest from investigators and patients in ...

CHICAGO -- Availability of a bevacizumab biosimilar for ophthalmic use could eliminate a lower-cost treatment option for a ...